Literature DB >> 8723059

Mosaic vs. nonmosaic trisomy 9: report of a liveborn infant evaluated by fluorescence in situ hybridization and review of the literature.

E S Cantú1, D J Eicher, G S Pai, C J Donahue, R A Harley.   

Abstract

We report on a newborn infant with multiple congenital anomalies and apparent nonmosaic trisomy 9 in the blood (by conventional cytogenetic studies) who died shortly after birth. Clinical observations at birth and autopsy are compared with phenotypes of mosaic and nonmosaic trisomy 9 cases reported previously. Unlike the initial cytogenetic analysis, fluorescence in situ hybridization (FISH) studies of metaphase and interphase blood cells and skin fibroblasts detected the presence of euploid and trisomy 9 cells. These results suggest that earlier reports of trisomy 9, which relied on conventional chromosome analysis of a few metaphase cells and/or only one tissue type, may not have excluded mosaicism, and that trisomy 9 may be viable only in the mosaic state.

Entities:  

Mesh:

Year:  1996        PMID: 8723059     DOI: 10.1002/(SICI)1096-8628(19960424)62:4<330::AID-AJMG1>3.0.CO;2-V

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Clinical manifestations in trisomy 9.

Authors:  T P Kannan; S Hemlatha; R Ankathil; B A Zilfalil
Journal:  Indian J Pediatr       Date:  2009-05-27       Impact factor: 1.967

2.  Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation.

Authors:  J M Friedman; Agnes Baross; Allen D Delaney; Adrian Ally; Laura Arbour; Linlea Armstrong; Jennifer Asano; Dione K Bailey; Sarah Barber; Patricia Birch; Mabel Brown-John; Manqiu Cao; Susanna Chan; David L Charest; Noushin Farnoud; Nicole Fernandes; Stephane Flibotte; Anne Go; William T Gibson; Robert A Holt; Steven J M Jones; Giulia C Kennedy; Martin Krzywinski; Sylvie Langlois; Haiyan I Li; Barbara C McGillivray; Tarun Nayar; Trevor J Pugh; Evica Rajcan-Separovic; Jacqueline E Schein; Angelique Schnerch; Asim Siddiqui; Margot I Van Allen; Gary Wilson; Siu-Li Yong; Farah Zahir; Patrice Eydoux; Marco A Marra
Journal:  Am J Hum Genet       Date:  2006-07-25       Impact factor: 11.025

Review 3.  Trisomy 9 mosaic syndrome: Sixteen additional patients with new and/or less commonly reported features, literature review, and suggested clinical guidelines.

Authors:  Mindy Li; Jennifer Glass; Xiaoli Du; Holly Dubbs; Margaret Horton Harr; Marni Falk; Teresa Smolarek; Robert J Hopkin; Elaine Zackai; Sarah E Sheppard
Journal:  Am J Med Genet A       Date:  2021-05-10       Impact factor: 2.578

4.  Partial trisomy 9: prenatal diagnosis and recurrence within same family.

Authors:  Jana López-Félix; Leticia Flores-Gallegos; Luz Garduño-Zarazúa; Teresa Leis-Márquez; Luz Juárez-García; Ricardo Meléndez-Hernández; Ernesto Castelazo-Morales; Dora Mayén-Molina
Journal:  Clin Case Rep       Date:  2017-05-10

5.  Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization.

Authors:  Jm Friedman; Shelin Adam; Laura Arbour; Linlea Armstrong; Agnes Baross; Patricia Birch; Cornelius Boerkoel; Susanna Chan; David Chai; Allen D Delaney; Stephane Flibotte; William T Gibson; Sylvie Langlois; Emmanuelle Lemyre; H Irene Li; Patrick MacLeod; Joan Mathers; Jacques L Michaud; Barbara C McGillivray; Millan S Patel; Hong Qian; Guy A Rouleau; Margot I Van Allen; Siu-Li Yong; Farah R Zahir; Patrice Eydoux; Marco A Marra
Journal:  BMC Genomics       Date:  2009-11-16       Impact factor: 3.969

6.  Report of a Case with Trisomy 9 Mosaicism.

Authors:  Mohammad Miryounesi; Mehdi Dianatpour; Zahra Shadmani; Soudeh Ghafouri-Fard
Journal:  Iran J Med Sci       Date:  2016-05

7.  The transcriptomes of novel marmoset monkey embryonic stem cell lines reflect distinct genomic features.

Authors:  Katharina Debowski; Charis Drummer; Jana Lentes; Maren Cors; Ralf Dressel; Thomas Lingner; Gabriela Salinas-Riester; Sigrid Fuchs; Erika Sasaki; Rüdiger Behr
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.